Microfluidics

#Leadership appointment #Life sciences #Microfluidics #Nuclera

Nuclera appoints Carl Raimond as Chief Executive Officer 

Nuclera has appointed Carl Raimond as Chief Executive Officer, effective immediately. Dr Michael Chen, Nuclera’s Co-founder and former CEO, transitions to the role of Chief Scientific and Business Officer, continuing to provide scientific leadership while supporting market development and strategic partnerships.  The leadership transition reportedly marks the… Read More

#News

Human brain
#AIS #Basking Biosciences #Biopharmaceuticals #Biosciences #Microfluidics #Stroke therapy

Basking Biosciences reports promising stroke therapy results

Basking Biosciences, a clinical-stage biopharmaceutical company developing a first-in-class, targeted, reversible thrombolytic therapy for acute ischemic stroke (AIS), has announced the publication of preclinical research in Communications Biology, a Nature Portfolio journal. The study shows that its lead candidate, BB-031, restores blood flow in a microfluidic model of arterial occlusion… Read More

#News

#Drug discovery #eBook #Microfluidics #Protein engineering

eBook: The future of protein science

A new eBook is now available for download for free from DDW and Nuclera.  Innovations in protein science are overcoming long-standing bottlenecks that have historically slowed drug discovery, industrial biotechnology, and synthetic biology. Traditional cell-based protein expression is slow, resource-intensive, and often fails for challenging targets such… Read More

#News

#Drug discovery #eBook #Microfluidics #Protein engineering

The future of protein science

Download this exclusive DDW eBook to learn more about: How Nuclera’s platform uses automation and microfluidics to make hard-to-express proteins fast, reliable, and ready for discovery. How cell-free protein synthesis and digital microfluidics are supercharging protein production, even for tricky proteins. Why traditional protein expression slows discovery and how automation… Read More

#eBooks #Resources

Ultrasonic microfluidic device
#Drug discovery #Microfluidics #Regenerative Medicine #University of Queensland

‘Smart’ microgel droplets support regenerative medicine research

Australian researchers have patented a new microfluidics tool that produces ‘smart’ microgel droplets for exploring regenerative medicines.  The platform was created by Dr Ruirui Qiao and her team at UQ’s Australian Institute for Bioengineering and Nanotechnology (AIBN).  Dr Qiao said her team’s UQ-Surf microfludics platform… Read More

#News

#AI / data analytics / healthtech / informatics #Covid-19 #Genomics #Machine learning #Microfluidics

New podcast: Reaching new heights with drug discovery

This is the latest episode of the free DDW narrated podcast, “Reaching new heights with drug discovery”. It covers two articles written for Volume 23, Issue 2 – Spring 2022 of DDW. They are called “High-throughput technologies: Reaching for the stars” and “… Read More

#News

#Cell and gene therapy #Funding #Microfluidics

€16.5m to advance automated, microfluidic CGT therapy 

Astraveus, providers of modular, microfluidic cell foundries for cell and gene therapy (CGT) manufacturing, has completed an oversubscribed €16.5 million Series Seed financing led by AdBio partners, co-syndicated with M Ventures, Johnson & Johnson Innovation – JJDC Inc., and Bpifrance Large Venture.  Astraveus’ Lakhesys platform is an… Read More

#Business & Investment #News

#Cell engineering #Microfluidics #Picodroplet technology #Sphere Fluidics

Reimagining cell engineering with picodroplet microfluidic technology

This paid-for advertorial by Sphere Fluidics appeared in the SLAS 2023 Supplement, Volume 24 – Issue 1, Winter 2022/2023 Cell engineering is being held back by lengthy and complicated multi-step workflows. Sphere Fluidics’ Cyto-Mine® system offers a streamlined, automated solution to this challenge using picodroplet microfluidic technology. Cell engineering is bringing… Read More

#Exclusive Content

#Drug development #Microfluidics #Organ-on-a-chip #Tissue chips

Using microfluidics in drug discovery

Download this 24-page DDW eBook, sponsored by Emulate, to learn about: How microfluidics is fuelling innovation in drug discovery A detailed look at the organ-on-a-chip sector How human tissue chips are helping advance our understanding of biology Download now. Read More

#DDW eBooks #Intelligence

Organ-on-a-chip
#Biopharma #Microfluidics #Organ-on-a-chip

eBook: Using microfluidics in drug discovery

This 24-page DDW eBook, sponsored by Emulate Bio, contains exclusive insight from industry experts on: How microfluidics is fuelling innovation in drug discovery A detailed look at the organ-on-a-chip sector How human tissue chips are helping advance our understanding of biology This guide is free of charge and you can… Read More

#News

#Drug screening #Funding #Innovate UK #Microfluidics

Orbit Discovery awarded grant to advance screening platform  

Biopharmaceutical company Orbit Discovery has been awarded almost £500,000 in a grant to help it expand its microfluidics screening capabilities.   The £472,000 Smart grant was awarded by Innovate UK and will facilitate the implementation of droplet-based microfluidics for cell-based functional screening and expand the capabilities and throughput… Read More

#News

#Biotechnology #CRISPR #Life sciences #Microfluidics

Advances in automated genome engineering 

Olivia Hughes from Sphere Fluidics discusses how advances in picodroplet microfluidics, combined with the high efficiency of CRISPR/Cas9 technology, are fuelling a new wave of innovation in the form of a simple click-through workflow for genome editing.  Picodroplet microfluidics is rapidly becoming the technology of choice for high-throughput single cell analysis, providing an… Read More

#Editor's Choice #Exclusive Content #News #Opinion

#Biochemistry #Drug development #Drug discovery #Life sciences #Microfluidics #Pharmaceuticals

Researchers develop tool to speed up the study of enzymes

Scientists understand that transformations that couldn’t historically be explained by conventional chemistry or physics alone are in fact powered by enzymes – protein molecules comprised of chains of amino acids that act to speed up, or catalyse, the conversion of one kind of molecule (substrates) into another (products). While more… Read More

#News

#Assays #Drug discovery #Microfluidics #Molecular Devices #Protein Fluidics

The workflow game-changer: combined technologies for efficiency

Oksana Sirenko, Senior Scientist, Molecular Devices and Evan Cromwell, President & CEO, Protein Fluidics, explain the benefits of automated organoid assays with microfluidics and 3D imaging. Microfluidic flowchip technology combined with three-dimensional (3D) imaging is a powerful duo poised to change the future of drug discovery and development. The integration… Read More

#Exclusive Content